Investigation of the changes in the intestinal microbiome of colitis mice
The aim of this study is to investigate whether MRA@RP (a therapeutic nanoagent developed by our group, treating colitis through comprehensive inflammation alleviation and immunoregulation) can have a regulation effect on the disrupted intestinal microbiome in colitis mice